DMRA
Damora Therapeutics, Inc.
20.70$
+2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.34 | 0.21 | 0.09 | 0.07 | 0.05 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.34 | -0.21 | -0.09 | -0.07 | -0.05 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 2.35 | 2.55 | 2.27 | 1.69 | 0.95 | 0.78 | 0.51 | 1.11 | 1.07 | 119.23 | 0.69 | 0.42 | 4.06 | |
| – | – | – | – | 2.40 | 1.32 | 1.45 | 1.48 | 1.31 | 2.45 | 0.21 | 0.15 | 0.36 | |
| 5.06 | 5.28 | 5.20 | 4.18 | 3.30 | 2.09 | 1.97 | 2.59 | 2.38 | 121.68 | 0.90 | 0.57 | 4.43 | |
| -5.40 | -5.49 | -5.29 | -4.25 | -3.35 | -2.10 | -1.97 | -2.59 | -2.38 | -121.68 | -0.90 | -0.57 | -4.43 | |
| -7.50 | -5.97 | -5.05 | -4.88 | -3.39 | -5.23 | -1.91 | -2.60 | -2.36 | -121.08 | -0.81 | -0.51 | -4.29 | |
| – | – | – | 0.04 | 0.01 | -0.01 | 0.00 | 0.00 | – | 0.03 | 0.00 | 0.00 | – | |
| -7.50 | -5.97 | -5.05 | -4.92 | -3.39 | -5.22 | -1.92 | -2.60 | -2.36 | -121.10 | -0.81 | -0.51 | -4.30 | |
| -7.17 | -5.76 | -4.96 | -4.81 | -3.33 | -5.23 | -1.91 | -2.59 | -2.35 | -121.07 | -0.81 | -0.57 | -4.36 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.